Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions

European Journal of Medical Research

Volumn 14, Issue SUPPL.4, 2009, Pages 128-133

  Korczynski, P ^a   Krenke, R ^a   Safianowska, A ^a   Gorska, K ^a   Abou Chaz, B M ^a   Maskey Warzechowska, M ^a   Kondracka, A ^a   Nasilowskil, J ^a   Chazan, R ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

cancer antigen 125; carcinoembryonic antigen; neuron specific enolase; pleural effusion

Indexed keywords

ANTIGEN CYFRA21.1; BIOLOGICAL MARKER; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; PLEURA EFFUSION; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CA-125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KERATIN-19; MALE; MIDDLE AGED; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; ROC CURVE;

EID: 77955498002     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-14-S4-128     Document Type: Article

References (17)

1. Thoracoscopy-state of the art. Loddenkemper R, Eur Respir J 1998 11 213 21 10.1183/09031936.98.11010213 9543295 (Pubitemid 28081820)
2. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Ferrer J, Villarino MA, Encabo G, Felip E, Bermejo B, Vila S, Orriols R, Cancer 1999 86 1488 95 10.1002/(SICI)1097-0142(19991015)86:8<1488::AID-CNCR15>3.0.CO;2-Y 10526277 (Pubitemid 29489782)
3. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Porcel JM, Vives M, Esquerda A, Salud A, Pérez B, Rodríguez-Panadero F, Chest 2004 126 1757 63 10.1378/chest.126.6.1757 15596670 (Pubitemid 39643976)
4. Pleural fluid adenosine deaminase and interferon gamma as diagnostic tools in tuberculosis pleurisy. Krenke R, Safianowska A, Paplinska M, Nasilowski J, Dmowska-Sobstyl B, Bogacka-Zatorska E, Jaworski A, Chazan R, J Physiol Pharmacol 2008 59 Suppl 6 349 60 19218659
5. Pleural diseases related to metastatic malignancies. Sahn SA, Eur Respir J 1997 10 1907 13 10.1183/09031936.97.10081907 9272937 (Pubitemid 27368388)
6. Tuberculous pleural effusions. Valdés L, Pose A, San José E, Martinez Vázquez JM, Eur J Intern Med 2003 14 77 88 10.1016/S0953-6205(03)00018-9 12719023 (Pubitemid 36457948)
7. Parapneumonic effusion and empyema. Hamm H, Light RW, Eur Respir J 1997 10 1150 6 10.1183/09031936.97.10051150 9163661 (Pubitemid 27201824)
8. Index for rating diagnostic tests. Youden WJ, Cancer 1950 3 32 5 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3 15405679
9. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions. Romero S, Fernández C, Arriero JM, Espasa A, Candela A, Martín C, Sánchez-Payá J, Eur Respir J 1996 9 17 23 10.1183/09031936.96.09010017 8834328 (Pubitemid 26038814)
10. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Lee JH, Chang JH, Chest 2005 128 2298 303 10.1378/chest.128.4.2298 16236887 (Pubitemid 41507572)
11. Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis. Gu P, Huang G, Chen Y, Zhu C, Yuan J, Sheng S, J Clin Lab Anal 2007 21 398 405 10.1002/jcla.20208 18022924 (Pubitemid 350250409)
12. Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion. Lai RS, Chen CC, Lee PC, Lu JY, Jpn J Clin Oncol 1999 29 421 4 10.1093/jjco/29.9.421 10563194
13. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions. Li CS, Cheng BC, Ge W, Gao JF, Int J Clin Pract 2007 61 444 8 10.1111/j.1742-1241.2006.01111.x 17313612
14. Diagnostic utility of CYFRA 21-1 in malignant pleural effusion. Dejsomritrutai W, Senawong S, Promkiamon B, Respirology 2001 6 213 6 10.1046/j.1440-1843.2001.00332.x 11555379 (Pubitemid 32896551)
15. Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre. Osman N, O'Leary N, Mulcahy E, Barrett N, Wallis F, Hickey K, Gupta R, Ir Med J 2008 101 245 7 18990955
16. Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis. Liang QL, Shi HZ, Qin XJ, Liang XD, Jiang J, Yang HB, Thorax 2008 63 35 41 10.1136/thx.2007.077958 17573438
17. Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis. Greco S, Girardi E, Masciangelo R, Capoccetta GB, Saltini C, Int J Tuberc Lung Dis 2003 7 777 86 12921155 (Pubitemid 36987942)